Michigan Administrative Code (Last Updated: November 16, 2016) |
Department LR. Licensing and Regulatory Affairs |
Bureau of Community and Health Systems |
Chapter Substance Used Disorder Programs |
Part 1. GENERAL PROVISIONS |
Section 325.14416. Take-home methadone; determination of client responsibility.
All data is extracted from pdf, click here to view the pdf.
-
(1) Take-home methadone shall only be given to a client who, in the reasonable clinical judgment of the program physician, is responsible in the handling of methadone. Before reducing the frequency of clinic visits, the rationale for this decision shall be recorded in the client's chart by a program physician or one of his or her designated staff. If a physician's designated staff member records the rationale for the decision, a program physician shall review, countersign, and date the client's record. Additionally, take-home methadone shall only be dispensed in an oral, liquid form so as to minimize its potential for abuse.
(2) It is recommended practice that this liquid vehicle be non-sweetened and contain a preservative so that a client can be instructed to keep take-home methadone out of the refrigerator in an attempt to minimize the likelihood of accidental overdoses by children and fermentation of the vehicle.
(3) The program physician shall, in the exercise of his or her reasonable clinical judgment, utilize all of the following information in determining whether or not a client is responsible enough to handle take-home methadone:
(a) Background and history of the client.
(b) General and special characteristics of the client and the community in which the client resides.
(c) Absence of recent abuse of non-narcotic drugs, including alcohol.
(d) Absence of current abuse of non-narcotic drugs and alcohol and narcotic drugs, including methadone.
(e) Regularity of clinic attendance.
(f) Absence of serious behavioral problems in the clinic.
(g) Stability of the client's home environment and social relationships.
(h) Absence of recent criminal activity.
(i) Length of time in methadone maintenance treatment.
(j) Assurance that take-home medication can be safely stored at home.
(k) Whether the rehabilitative benefit to the patient derived from decreasing the frequency of clinic attendance outweighs the potential risks of diversion.
History: 1981 AACS.